Skip to main content
. 2014 Dec 6;29(1):132–138. doi: 10.1080/13102818.2014.987514

Figure 5.

Figure 5.

Immunostaining of CD68 in the liver section. (A) blank control group; (B) 25 mg/kg silymarin treatment group; (C) 100 mg/kg DHP1A treatment group; (D) 200 mg/kg DHP1A treatment group; (E) CCl4 treatment group; (F) 25 mg/kg silymarin + CCl4 treatment group; (G) 100 mg/kg DHP1A + CCl4 treatment group and (H) 200 mg/kg DHP1A + CCl4 treatment group.